Breathe Well Live Well
Xconomy |
Houston's Fannin Launches New Biotech, Exotect, to Treat Asthma
Xconomy Asthma treatments have typically focused on treating inflammation and constricted airways. Houston's Fannin Innovation Studio has launched a company that tackles the disease's third symptom: reducing overproduction of mucus. The company, called … |
View full post on asthma – Google News
Xconomy |
Propeller Health Takes Off With Digital Tracker for Asthma
Xconomy The holiday season just past was a feast for the senses—decorations, scented candles, fresh-cut evergreens, and the happy faces of visitors. But all the household cleaning and holiday decorating can also set off an asthma attack, as some sufferers … |
View full post on asthma – Google News
|
Array Shares Climb After Asthma Drug Shows Positive Phase 2 Results
Xconomy Array hopes ARRY-502 can become the next successful oral treatment for asthma, CEO Ron Squarer said during a conference call about the results. The market is substantial, and it has been 15 years since the FDA last approved an oral non-steroidal drug … |
View full post on asthma – Google News
 Xconomy |
Knome Names New CEO, Cuts Deal With Johns Hopkins to Analyze 1000 Genomes
Xconomy The company is announcing today that it has won a new contract to analyze and compare 1000 genomes for scientists at Johns Hopkins University, who are looking for genetic variants linked to asthma in African American and African Caribbean populations. … Knome Selected as Technology Partner by Johns Hopkins for Landmark 1000 … |
View full post on asthma – Google News
|
Isis Spinoff Altair Therapeutics Shut Down, After Mid-Stage Asthma Study Fails
Xconomy … has shut down operations after the startup's only drug candidate failed in a mid-stage clinical trial against asthma, Xconomy has learned. … |
View full post on asthma – Google News